Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Margreet G. Franken*, Brenda Leeneman, Anouk Jochems, Maartje G. Schouwenburg, Maureen J. B. Aarts, Alexander C. J. van Akkooi, Franchette W. P. . J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Koos J. M. van der Hoeven, Geke A. P. Hospers, Ellen Kapiteijn, Rutger Koornstra, Wim H. J. Kruit, Marieke W. J. Louwman, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J. ten Tije, Gerard VreugdenhilMichel W. J. M. Wouters, Michiel van Zeijl, John B. A. G. Haanen, Carin A. Uyl-de Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science